- Home
- QUBT vs AAPG Comparison
QUBT vs AAPG Comparison
Compare QUBT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUBT
- AAPG
- Stock Information
- Founded
- QUBT 2001
- AAPG 2009
- Country
- QUBT United States
- AAPG China
- Employees
- QUBT N/A
- AAPG N/A
- Industry
- QUBT Computer Manufacturing
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- QUBT Technology
- AAPG Health Care
- Exchange
- QUBT Nasdaq
- AAPG Nasdaq
- Market Cap
- QUBT 3.5B
- AAPG 3.6B
- IPO Year
- QUBT N/A
- AAPG 2025
- Fundamental
- Price
- QUBT $16.71
- AAPG $33.42
- Analyst Decision
- QUBT Strong Buy
- AAPG Buy
- Analyst Count
- QUBT 3
- AAPG 1
- Target Price
- QUBT $26.33
- AAPG N/A
- AVG Volume (30 Days)
- QUBT 49.2M
- AAPG 7.5K
- Earning Date
- QUBT 11-14-2025
- AAPG 11-19-2025
- Dividend Yield
- QUBT N/A
- AAPG N/A
- EPS Growth
- QUBT N/A
- AAPG N/A
- EPS
- QUBT N/A
- AAPG N/A
- Revenue
- QUBT $263,000.00
- AAPG $54,524,554.00
- Revenue This Year
- QUBT $11.21
- AAPG N/A
- Revenue Next Year
- QUBT $412.29
- AAPG $368.64
- P/E Ratio
- QUBT N/A
- AAPG N/A
- Revenue Growth
- QUBT N/A
- AAPG N/A
- 52 Week Low
- QUBT $1.03
- AAPG $16.50
- 52 Week High
- QUBT $27.15
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- QUBT 46.76
- AAPG 37.48
- Support Level
- QUBT $14.70
- AAPG $32.68
- Resistance Level
- QUBT $17.35
- AAPG $35.07
- Average True Range (ATR)
- QUBT 1.79
- AAPG 0.88
- MACD
- QUBT -0.34
- AAPG -0.11
- Stochastic Oscillator
- QUBT 28.56
- AAPG 15.35
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.